Intel vs Roche: Founders, CEOs and History
Intel was founded in 1968 by Robert Noyce, Gordon Moore and is led by Lip-Bu Tan. Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker.
Company facts
Founders
Intel
Robert Noyce
Intel possesses the most well-known founding story in the entire history of Silicon Valley, famously founded by the effective, rebellious engineers who essentially invented the fundamental architecture of the modern digital world.
Gordon Moore
Gordon Moore co-founded Intel and served as a key technical leader, CEO, and chairman during the company's formative decades. His most important contribution was turning transistor scaling into a corporate operating philosophy.
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
CEOs and their tenures
Intel
- Andy Grove1987–1998
CEO
Grove turned Intel into the dominant PC processor supplier; revenue grew from about $1.9B in 1987 to over $26B in 1998. His book 'Only the Paranoid Survive' became a management classic.
Source - Pat Gelsinger2021–2024
CEO
Gelsinger rebuilt Intel's process roadmap toward 18A, but capital spending outpaced revenue. After a $18.8B net loss in 2024 and a dividend suspension, the board pushed him out in December 2024.
Source - Lip-Bu Tan2025–present
Chief Executive Officer
Tan reframed Intel around customer commitments and cost discipline rather than building capacity ahead of demand. By Q2 2026 Intel had beaten guidance for several straight quarters and posted its fastest revenue growth in more than 15 years.
Source
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
Timeline: Intel and Roche side by side
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1968Intel
Intel Founded
Robert Noyce and Gordon Moore founded Intel.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
1971Intel
4004 Microprocessor
Intel introduced the 4004, one of the first commercial microprocessors.
1985Intel
386 Processor
Intel strengthened the x86 franchise that later dominated PCs.
1993Intel
Pentium Processor Launched
Intel introduced the Pentium processor in 1993.
2006Intel
Core Architecture
Intel revived product leadership with the Core architecture.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2021Intel
IDM 2.0 Announced
Intel announced a strategy to expand manufacturing and foundry capabilities.
2021Intel
Pat Gelsinger Becomes CEO
Pat Gelsinger became Intel chief executive in February 2021.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2025Intel
Lip-Bu Tan Becomes CEO
Lip-Bu Tan became CEO and reset the turnaround agenda around execution, cost, and focus.
2025Intel
$52.853B Revenue
Intel reported $52.853B in revenue and a $267M net loss attributable to Intel.
2025Intel
U.S. Government Takes 9.9% Stake
The U.S. government bought 433.3 million Intel shares at $20.47 for $8.9 billion, becoming the largest shareholder.
2025Intel
Nvidia Invests $5 Billion
Nvidia agreed to invest $5 billion in Intel and co-develop x86 PC and data-center products.
2025Intel
Altera Majority Sold
Intel closed the sale of 51% of Altera to Silver Lake on September 12, 2025.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
2026Intel
Q2 Revenue Up 25%
Intel reported $16.1 billion in Q2 2026 revenue, its fastest growth in more than 15 years.
Acquisitions
Intel
- Moovit2020$900M
- Habana Labs2019$2B
- Mobileye2017$15.3B
- Altera2015$16.7B
- McAfee2011$7.7B
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
Questions about Intel vs Roche
Who is the CEO of Intel Corporation and F. Hoffmann-La Roche AG?
Intel Corporation is led by Lip-Bu Tan and F. Hoffmann-La Roche AG is led by Thomas Schinecker. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Intel Corporation founded vs F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG was founded in 1896 — 72 years before Intel Corporation, which was founded in 1968. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Intel Corporation.
How many employees does Intel Corporation have compared to F. Hoffmann-La Roche AG?
Intel Corporation employs approximately 85,100 people, while F. Hoffmann-La Roche AG employs approximately 112,774. F. Hoffmann-La Roche AG has the larger workforce at 112,774 employees, compared to Intel Corporation's 85,100. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Intel Corporation and F. Hoffmann-La Roche AG headquartered?
Intel Corporation is headquartered in United States and F. Hoffmann-La Roche AG is headquartered in Switzerland. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Intel Corporation and F. Hoffmann-La Roche AG?
Intel Corporation was founded by Robert Noyce, Gordon Moore. F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche.
Which company has a longer operating history — Intel Corporation or F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. Intel Corporation has been in operation for around 58 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Intel vs Roche overview